The global digital pathology market size was valued at USD 321.7 million in 2016. It is expected to witness a CAGR of 12.0% during the forecast period. Increasing focus on improving workflow efficiency and implementing faster diagnostic tools for chronic diseases, such as cancer, is one of the key trends triggering market growth.
Rising prevalence of chronic conditions is estimated to drive the market. An upsurge is anticipated in clinical urgency to adopt digital pathology in order to improve existing patient diagnostic imaging measures and reduce high cost associated with these conventional diagnostics. As aged people are more susceptible to chronic conditions, growing geriatric population is likely to boost the demand for technologically advanced diagnostic techniques, thereby augmenting the market.
According to a study published in Medscape, chronic diseases are responsible for high mortality rate. Owing to the high prevalence of cardiovascular diseases, it becomes imperative to opt for advanced diagnostic and imaging alternatives. Whole slide imaging is one such technique that has various advantages over conventional light microscopes, which is expected to provide with lucrative opportunities.
Moreover, rapid technological advancements in digital pathology systems are playing a pivotal role in the development of the market. Advancements such as advanced visualization, computerization, robotic light microscopy, and multiple fiber optic communications are projected to contribute to the growth of the market.
In addition, advancements such as microarrays and incorporation of a wide range of predictive models such as hybrid models and various API algorithms are poised to fuel the demand for image analysis software, further accentuating the overall demand. Rising preference for computer-aided diagnosis that integrates image processing, physics, mathematics, and computing algorithms facilitates efficient disease detection. It also helps in evaluating anatomic structures of interest and quantification of disease progression as well as risk assessment. These aforementioned benefits offered by digital pathology systems are expected to provide an upthrust to the market.
The whole slide imaging segment dominated the market in terms of revenue share in 2016. Increasing adoption of this system for academic research activities and enhanced resolution are the key growth stimulants for the segment. This technology is projected to experience significant growth during the forecast period owing to advancements in magnification and scanning of slides at Z axis, which are offered by whole slide imaging.
Adoption of telepathology is relatively low and this accounts for a comparatively smaller share in 2016. High cost of software implementation & maintenance, complex system, security issues, inconvenience in selection of slides, and cost of set up are the factors hindering the adoption of this technology in medical field.
However, increasing R&D pertaining to applications of static and dynamic systems is poised to rev up the usage rate of this technology in near future. For instance, hybrid telepathology, which is the combination of static & dynamic systems, has advantages of both the systems and is expected to gain popularity during the forecast period.
The static system held a major share of telepathology owing to various associated advantages, including cost-effectiveness, efficiency, and reliability. On the other hand, dynamic system is estimated to register a remarkable CAGR over the forecast period, as it is a more appropriate system for frozen section.
Based on application, the digital pathology market is segmented into drug discovery & development, academic research, and diagnosis. The academic research segment dominated the market, owing to its wide applications in various research procedures such as biomarker profiling and tumor morphological study.
The diagnosis segment is anticipated to witness the fastest growth over the forecast period due to increasing prevalence of chronic diseases. In addition, rising focus of manufacturers on development of novel and rapid diagnostic techniques is likely to stoke the growth of the segment.
Digital pathology is helpful in providing accurate & faster detection and diagnosis of chronic diseases. It automatically detects tumor at inflammatory and proliferating stromal cells stage, thereby, curbing cost pertaining to abnormal cell detection. It also reduces cost by omitting requirement of Fluorescence In-situ Hybridization (FISH) tests and impacts laboratory workflow positively. Through this technology, information about a patient is generated in the form of online slides, which can be viewed on a computer monitor anywhere.
Digital pathology also allows sharing information for publication, research, diagnosis, and education through the internet. Thus, it reduces sharing costs. Traditionally, to obtain accurate tumor diagnosis results, multiple tests were carried out, which have been reduced to a single test performed using digital pathology system.
This technology has a zoom in and zoom out facility, so that affected areas can be viewed clearly, thus helping save time. Digital pathology has also reduced paperwork and now patients do not have to wait for several days to obtain results. Global access of digitalized slides also reduce re-examination costs for patients.
Hospitals commanded the largest share in the market in 2016. The growth of the segment can be attributed to rising number of cancer cases coupled with frequent readmissions. Presence of the well-equipped infrastructure, well-trained and skilled staff, and a large number of procedures frequently taking place are propeling the growth of the segment.
In addition, numerous readmissions along with increasing patient turnaround are projected to help the segment expand at a noteworthy CAGR during the forecast period. Furthermore, hospitals work closely with government bodies and suppliers, which is poised to positively influence the growth of the segment. Also, increasing initiatives taken by governments to promote advanced healthcare systems are expected to provide a fillip to the overall market.
Diagnostic centers are estimated to post the highest CAGR over the forecast period, owing to rising incidence of cancer and diabetes all over the world. The market has been impacted by development of whole slide imaging (WSI) technology for diagnostic purposes. The automated whole slide imaging scanner is a microscope, which employs software to merge individual captured images into a whole new digitalized image.
In 2016, North America was the leading revenue contributor in the market. Increasing investments in R&D activities, supportive government initiatives pertaining to development of technologically advanced systems, and strong presence of major players in the region are contributing to its dominance.
Increasing usage of digital pathology for disease diagnosis and favorable reimbursement policies in the U.S. for improving the quality of cancer diagnosis are estimated to supplement the growth of the region.
Asia Pacific is anticipated to exhibit the fastest CAGR of over 13.2% during the forecast period due to proliferation of advanced imaging modalities in emerging economies, growing investments in medical field, and presence of untapped opportunities. Presence of a large target patient population and booming healthcare industry are encouraging the growth of the regional market. In addition, spiraling demand for novel treatment options, better patient care facilities, and reduction in laboratory expenses are likely to spur the demand for digital pathology systems in the region.
Key market participants include Omynx LLC; 3DHistech, Inc.; Definiens; Olympus Corporation; GE Healthcare; Leica Biosystems; Philips Healthcare; Ventana Medical Systems, Inc.; Objective Pathology Services; Hamamatsu Photonics, Inc.; LigoLAb LLC; and MicroSkan Technologies. These key players adopt extensive sustainability strategies, such as new product development and regional & distribution channel expansion, in order to attain a greater share in the market.
Recently, in June 2016, a Dutch conglomerate, Royal Philips, acquired the Irish PathXL, one of the largest image-based analysis firms. This acquisition was carried out in order to develop integrated tools targeting applications in computational biology, workflow solutions, education, and image analytics.
In addition, this acquisition is aimed at underpinning the gradual transition of medical institutions present across the globe from traditional systems to digitized pathology systems. Thus, the aforementioned acquisition will further enable pathologists perform high-throughput analysis of colossal clinical image datasets that are diverse in nature and facilitate improvement in the diagnosis quality. This will, thereby, present a potential for inclusion of new therapies to enhance patient health outcomes.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Volume in Thousand Units, Revenue in USD Million, and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, U.K., Japan, China, India, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global digital pathology market report on the basis of technology, application, end-use, and region:
Technology Outlook (Revenue, USD Million; Volume, ‘000 Units, 2014 - 2025)
Whole Slide Imaging
Application Outlook (Revenue, USD Million, 2014 - 2025)
Drug Discovery & Development
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
United Arab Emirates
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."